Pay-for-performance in healthcare

BOSTON--Although the idea of pay-for-performance (P4P) is popular among healthcare policy makers and private insurers, the results do not necessarily translate to the patient.

Novel compound selectively kills cancer cells

A cancer cell may seem out of control, growing wildly and breaking all the rules of orderly cell life and death. But amid the seeming chaos there is a balance between a cancer cell's revved-up metabolism and skyrocketing ...

SKorea says Samsung chip plant caused cancer

(AP)—A South Korean government agency said Friday that working at a Samsung Electronics factory caused the breast cancer of a worker who died earlier this year, only the second time it has recognized a link between cancer ...

New Cancer Drug Delivery System Is Effective and Reversible

For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug also must spare healthy cells, and ideally its effects will be reversible to cut short any potentially dangerous side ...

Nanodiamonds take big step toward battling cancer

Chemotherapy drug resistance contributes to treatment failure in more than 90 percent of metastatic cancers. Overcoming this hurdle would significantly improve cancer survival rates.

Facebook donates servers to speed up research into AI (Update)

Facebook announced Thursday it was donating computer servers to a number of research institutions across Europe, starting with Germany, to accelerate research efforts into artificial intelligence (AI) and machine learning.

Tracking therapeutic nanoparticles that target breast tumors

Researchers at Rice University, collaborating with investigators at the Baylor College of Medicine, have used two different types of imaging technologies to track the delivery of a therapeutic nanoparticle to breast tumors. ...

New nanotech weapon takes aim at hard-to-treat breast cancer

Breast cancer in its various forms affects more than 250,000 Americans a year. One particularly aggressive and hard-to-treat type is triple-negative breast cancer (TNBC), which lacks specific receptors targeted by existing ...

page 13 from 36